Literature DB >> 16952841

Surgical management of peritoneal carcinomatosis: from clinical research to standard of care.

Santiago González-Moreno.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16952841     DOI： 10.1007/s12094-006-0058-0

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN： 1699-048X            Impact factor:   3.405


× No keyword cloud information.
  13 in total

1.  Clinical research to standard of care: when does the transition occur?

Authors:  Paul H Sugarbaker
Journal:  Ann Surg Oncol       Date:  2003-10       Impact factor: 5.344

2.  Peritoneal carcinomatosis or liver metastases from colorectal cancer: similar standards for a curative surgery?

Authors:  Dominique M Elias
Journal:  Ann Surg Oncol       Date:  2004-02       Impact factor: 5.344

3.  Intraperitoneal cisplatin and paclitaxel in ovarian cancer.

Authors:  Deborah K Armstrong; Brian Bundy; Lari Wenzel; Helen Q Huang; Rebecca Baergen; Shashikant Lele; Larry J Copeland; Joan L Walker; Robert A Burger
Journal:  N Engl J Med       Date:  2006-01-05       Impact factor: 91.245

Review 4.  Intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: current status and future directions.

Authors:  John H Stewart; Perry Shen; Edward A Levine
Journal:  Ann Surg Oncol       Date:  2005-08-18       Impact factor: 5.344

Review 5.  [Cytoreductive surgery and perioperative intraperitoneal chemotherapy for neoplasms with peritoneal dissemination: the time has come].

Authors:  Santiago González-Moreno
Journal:  Cir Esp       Date:  2005-12       Impact factor: 1.653

Review 6.  Systemic therapy for metastatic colorectal cancer: current options, current evidence.

Authors:  Hanna Kelly; Richard M Goldberg
Journal:  J Clin Oncol       Date:  2005-07-10       Impact factor: 44.544

7.  Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer.

Authors:  D S Alberts; P Y Liu; E V Hannigan; R O'Toole; S D Williams; J A Young; E W Franklin; D L Clarke-Pearson; V K Malviya; B DuBeshter
Journal:  N Engl J Med       Date:  1996-12-26       Impact factor: 91.245

8.  Phase I and pharmacological studies of 5-fluorouracil administered intraperitoneally.

Authors:  J L Speyer; J M Collins; R L Dedrick; M F Brennan; A R Buckpitt; H Londer; V T DeVita; C E Myers
Journal:  Cancer Res       Date:  1980-03       Impact factor: 12.701

9.  Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer.

Authors:  Vic J Verwaal; Serge van Ruth; Eeclo de Bree; Gooike W van Sloothen; Harm van Tinteren; Henk Boot; Frans A N Zoetmulder
Journal:  J Clin Oncol       Date:  2003-10-15       Impact factor: 44.544

10.  Treatment of peritoneal carcinomatosis from colorectal cancer: impact of complete cytoreductive surgery and difficulties in conducting randomized trials.

Authors:  Dominique Elias; Jean-Robert Delperro; Lucas Sideris; Ellen Benhamou; Marc Pocard; Olivier Baton; Marc Giovannini; Philippe Lasser
Journal:  Ann Surg Oncol       Date:  2004-05       Impact factor: 5.344
View more
  1 in total

1.  Pseudomyxoma peritonei: a rare disease and a disease model in peritoneal surface oncology.

Authors:  Santiago González-Moreno
Journal:  Clin Transl Oncol       Date:  2011-04       Impact factor: 3.405
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.